Drugs / ALVAC-HIV MN120TMGNP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001072 | ? → Jan 1999 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALVAC-HIV MN120TMGNP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001072 ↗ |
| Known as | vCP300 | “ALVAC-HIV MN120TMGNP (vCP300)” NCT00001072 ↗ |